Cone Beam CT Scanning in Lung and Bladder Cancer.

This study has been completed.

Sponsor:

Collaborator:

Cross Cancer Institute

Information provided by (Responsible Party):

AHS Cancer Control Alberta

ClinicalTrials.gov Identifier:

NCT00469066

First received: May 2, 2007

Last updated: February 23, 2016

Last verified: December 2011

History of Changes

Purpose

To study changes in tumor and normal organ size and/or position which occur during a course of radiation treatments.

Condition
Lung Neoplasm Small Cell Carcinoma Bladder Carcinoma


Study Type:	Observational
Study Design:	Observational Model: Case-Only Time Perspective: Prospective
Official Title:	Improving the Accuracy of Radiotherapy Planning and Delivery Using Kilovoltage Cone Beam CT Imaging

Resource links provided by NLM:

Genetics Home Reference related topics: bladder cancer lung cancer

MedlinePlus related topics: Bladder Cancer

U.S. FDA Resources

Further study details as provided by AHS Cancer Control Alberta:


Enrollment:	22
Study Start Date:	May 2007
Study Completion Date:	April 2010
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)

Eligibility


Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

primary care clniic

Criteria

Inclusion Criteria:

Patient has biopsy proven limited stage SCLC
receiving radical concurrent chemoradiotherapy
no prior chest RT
no prior surgical resection of lung tumor
no prior chemotherapy
patients' lung tumors should be centrally-located to minimize the effect of respiratory motion
patient has biopsy proven TCC bladder
receiving radical concurrent chemoradiotherapy or RT alone
no prior chemotherapy
patient signs study-specific consent form

Exclusion Criteria:

mixed small cell and non small cell histology
patient not being treated with concurrent chemoradiotherapy
chemoradiotherapy given sequentially
previous chest RT
previous chemotherapy
prior surgical resection of lung mass
patient ineligible for pelvic RT
patient does not sign study consent

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00469066

Locations


Canada, Alberta
Cross Cancer Institute
Edmonton, Alberta, Canada

Sponsors and Collaborators

AHS Cancer Control Alberta

Cross Cancer Institute

Investigators


Principal Investigator:	Don Yee, MD	AHS Cancer Control Alberta

More Information


Responsible Party:	AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:	NCT00469066 History of Changes
Other Study ID Numbers:	LU-11-0073
Study First Received:	May 2, 2007
Last Updated:	February 23, 2016

Keywords provided by AHS Cancer Control Alberta:


small cell lung cancer bladder cancer conformal radiotherapy

Additional relevant MeSH terms:


Carcinoma Lung Neoplasms Urinary Bladder Neoplasms Carcinoma, Small Cell Small Cell Lung Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms	Neoplasms by Site Lung Diseases Respiratory Tract Diseases Urologic Neoplasms Urogenital Neoplasms Urinary Bladder Diseases Urologic Diseases Carcinoma, Bronchogenic Bronchial Neoplasms

ClinicalTrials.gov processed this record on July 21, 2017

To Top